Pfizer–BioNTech COVID-19 vaccine
"I hope that another type of vaccine will be developed soon, according to the classic method, long-lasting vaccines, multifactorial, which with one injection will completely protect us from current and future variants of the coronavirus."
This was said on BNR by the infectious disease specialist Prof. Georgi Popov from Sofiamed University Hospital.
Professor of Health Policy at LSE Elias Mosialos wrote on the approval of the coronavirus vaccine for children and specifically for the ages of 5 to 11 years, the , by posting an extended message on his personal Facebook account.
Prof. Mosialos refers to the clinical trials that were carried out until the licensing of vaccines for children aged 5 to 11 years.